SCHEMBL21596850

SCHEMBL21596850

COc1cc2c(c(OC)c1)CCC2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 5/20 0.44
HTR1A P08908 1/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ACHE P22303 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
NFE2L2 Q16236 2/20 0.40
EGFR P00533 1/20 0.40
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
PARP1 P09874 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31605597 1.00 DRD1 (0.44) DRD1HTR1AMEN1KMT2AACHE
SCHEMBL15199239 0.82 EGFR (0.41) DRD1ACHEALDH1A1CYP3A4NFE2L2
SCHEMBL23731386 0.80 EGFR (0.40) DRD1ACHEALDH1A1NFE2L2EGFR
SCHEMBL8809826 0.79 CYP19A1 (0.43) ACHEALDH1A1
SCHEMBL22618628 0.78 NQO2 (0.38) ALDH1A1CYP1A2CYP3A4
SCHEMBL21357843 0.78 CYP3A4 (0.47) MEN1KMT2AACHECYP1A2CYP3A4
SCHEMBL30777410 0.78 CYP3A4 (0.47) MEN1KMT2AACHECYP1A2CYP3A4
SCHEMBL3293104 0.78 ALDH1A1 (0.40) MEN1KMT2AACHEALDH1A1CYP3A4
SCHEMBL29383412 0.78 NQO2 (0.38) ALDH1A1CYP1A2CYP3A4
SCHEMBL27946095 0.78 TAAR1 (0.40) DRD1KMT2AACHEALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 DRD1 2065/4885HTR1A 2406/4885MEN1 122/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 DRD1 2070/4885HTR1A 2405/4885MEN1 121/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B DRD1 74/4885HTR1A 478/4885MEN1 866/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 DRD1 2070/4885HTR1A 2405/4885MEN1 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.